Variant report

Variant	nsv1016147
Chromosome Location	chr6:164765938-165046731
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:885)
CpG islands
(count:427)
Chromatin interactive
region (count:59)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:885 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:164767622-164767980	K562	blood:	n/a	n/a
2	ARID3A	chr6:164798491-164798683	K562	blood:	n/a	n/a
3	ATF1	chr6:164918144-164918284	K562	blood:	n/a	n/a
4	ATF1	chr6:164767707-164768041	K562	blood:	n/a	n/a
5	ATF2	chr6:164926459-164926870	GM12878	blood:	n/a	n/a
6	ATF2	chr6:164928321-164929043	GM12878	blood:	n/a	n/a
7	ATF2	chr6:164765756-164766224	H1-hESC	embryonic stem cell:	n/a	n/a
8	ATF2	chr6:164928270-164929113	GM12878	blood:	n/a	n/a
9	ATF3	chr6:164768570-164768730	K562	blood:	n/a	n/a
10	BATF	chr6:164928521-164929021	GM12878	blood:	n/a	n/a
11	BATF	chr6:164952830-164953115	GM12878	blood:	n/a	chr6:164952982-164952993
12	BATF	chr6:164898863-164899130	GM12878	blood:	n/a	n/a
13	BATF	chr6:164952872-164953114	GM12878	blood:	n/a	chr6:164952982-164952993
14	BATF	chr6:164898891-164899123	GM12878	blood:	n/a	n/a
15	BATF	chr6:164928549-164928927	GM12878	blood:	n/a	n/a
16	BATF	chr6:164926445-164926910	GM12878	blood:	n/a	n/a
17	BCL11A	chr6:164928408-164928949	GM12878	blood:	n/a	n/a
18	BCL11A	chr6:164928320-164929011	GM12878	blood:	n/a	n/a
19	BCL11A	chr6:164926483-164926915	GM12878	blood:	n/a	n/a
20	BCL11A	chr6:164765922-164766293	H1-hESC	embryonic stem cell:	n/a	n/a
21	BCL3	chr6:164928630-164929027	GM12878	blood:	n/a	n/a
22	BCL3	chr6:164926405-164926609	GM12878	blood:	n/a	n/a
23	BCLAF1	chr6:164928419-164929054	GM12878	blood:	n/a	n/a
24	BCLAF1	chr6:164928453-164929082	GM12878	blood:	n/a	n/a
25	BHLHE40	chr6:164953286-164953312	GM12878	blood:	n/a	n/a
26	BHLHE40	chr6:164926462-164926801	GM12878	blood:	n/a	n/a
27	BHLHE40	chr6:164928355-164929088	GM12878	blood:	n/a	n/a
28	BHLHE40	chr6:164952948-164953079	GM12878	blood:	n/a	n/a
29	BHLHE40	chr6:164826224-164826542	K562	blood:	n/a	n/a
30	CBX3	chr6:164825821-164826135	K562	blood:	n/a	n/a
31	CBX3	chr6:164777916-164778190	K562	blood:	n/a	n/a
32	CBX3	chr6:164802633-164802852	K562	blood:	n/a	n/a
33	CBX3	chr6:164767637-164768036	K562	blood:	n/a	n/a
34	CBX3	chr6:164768484-164768814	K562	blood:	n/a	n/a
35	CBX3	chr6:164947063-164947378	K562	blood:	n/a	n/a
36	CCNT2	chr6:164767714-164768074	K562	blood:	n/a	n/a
37	CCNT2	chr6:164858191-164858336	K562	blood:	n/a	n/a
38	CCNT2	chr6:164889314-164889407	K562	blood:	n/a	n/a
39	CEBPB	chr6:164920704-164920887	K562	blood:	n/a	n/a
40	CEBPB	chr6:164798394-164798659	K562	blood:	n/a	n/a
41	CEBPB	chr6:164863787-164863956	K562	blood:	n/a	n/a
42	CEBPB	chr6:164912685-164912887	HepG2	liver:	n/a	chr6:164912760-164912769 chr6:164912760-164912769 chr6:164912760-164912769 chr6:164912758-164912771 chr6:164912758-164912769 chr6:164912760-164912769 chr6:164912758-164912771 chr6:164912760-164912771 chr6:164912718-164912729
43	CEBPB	chr6:164996421-164996674	HepG2	liver:	n/a	chr6:164996578-164996589
44	CEBPB	chr6:164765798-164766625	H1-hESC	embryonic stem cell:	n/a	chr6:164766519-164766530
45	CEBPB	chr6:164767594-164768100	K562	blood:	n/a	n/a
46	CEBPB	chr6:164798384-164798726	K562	blood:	n/a	n/a
47	CEBPB	chr6:164920224-164920430	HepG2	liver:	n/a	chr6:164920299-164920312 chr6:164920300-164920311
48	CEBPB	chr6:164899513-164899619	H1-hESC	embryonic stem cell:	n/a	n/a
49	CEBPB	chr6:164798376-164798710	K562	blood:	n/a	n/a
50	CEBPB	chr6:164928530-164929093	GM12878	blood:	n/a	n/a

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:164817337-164817387	HIPEpiC	eye:	n/a
2	chr6:165032072-165032122	ECC-1	luminal epithelium:	n/a
3	chr6:164817337-164817387	HCM	heart:	n/a
4	chr6:164990879-164990929	NB4	blood:	n/a
5	chr6:165032072-165032122	HRE	kidney:	n/a
6	chr6:165032068-165032118	HepG2	liver:	n/a
7	chr6:165032072-165032122	GM12892	blood:	n/a
8	chr6:164975487-164975537	AG10803	skin:	n/a
9	chr6:164767056-164767106	HEK293	kidney:	embryo
10	chr6:165032124-165032174	AoSMC	blood vessel:	n/a
11	chr6:164990879-164990929	LNCaP	prostate:	n/a
12	chr6:165032068-165032118	SK-N-SH_RA	brain:	n/a
13	chr6:164975487-164975537	BJ	skin:	n/a
14	chr6:165032072-165032122	NT2-D1	testis:	n/a
15	chr6:165032124-165032174	HCPEpiC	choroid plexus:	n/a
16	chr6:164990879-164990929	HEEpiC	esophagus:	n/a
17	chr6:165032124-165032174	AG04450	lung:	fetal
18	chr6:164767056-164767106	HCPEpiC	choroid plexus:	n/a
19	chr6:165032068-165032118	HL-60	blood:	n/a
20	chr6:165032124-165032174	NH-A	brain:	n/a
21	chr6:164990879-164990929	SKMC	muscle:	n/a
22	chr6:165032072-165032122	H1-hESC	embryonic stem cell:	embryo
23	chr6:165032068-165032118	AG09319	gingival:	n/a
24	chr6:164817337-164817387	LNCaP	prostate:	n/a
25	chr6:164817337-164817387	PrEC	prostate:	n/a
26	chr6:164990879-164990929	GM12891	blood:	n/a
27	chr6:164767056-164767106	HCF	heart:	n/a
28	chr6:165032124-165032174	HRPEpiC	eye:	n/a
29	chr6:165032072-165032122	HPAEpiC	pulmonary alveolar:	n/a
30	chr6:164975487-164975537	Caco-2	colon:	n/a
31	chr6:164767056-164767106	HCT-116	colon:	n/a
32	chr6:165032072-165032122	BJ	skin:	n/a
33	chr6:164990879-164990929	K562	blood:	n/a
34	chr6:164817337-164817387	HNPCEpiC	eye:	n/a
35	chr6:164990879-164990929	H1-hESC	embryonic stem cell:	embryo
36	chr6:164990879-164990929	HNPCEpiC	eye:	n/a
37	chr6:164817337-164817387	MCF-7	breast:	n/a
38	chr6:164817337-164817387	HMEC	breast:	n/a
39	chr6:165032068-165032118	HNPCEpiC	eye:	n/a
40	chr6:164817337-164817387	AG09319	gingival:	n/a
41	chr6:164990879-164990929	U87	brain:	n/a
42	chr6:165032072-165032122	GM06990	blood:	n/a
43	chr6:164767056-164767106	NHDF-neo	bronchial:	n/a
44	chr6:164975487-164975537	MCF10A-Er-Src	breast:	n/a
45	chr6:165032072-165032122	SKMC	muscle:	n/a
46	chr6:165032124-165032174	PrEC	prostate:	n/a
47	chr6:165032068-165032118	AoSMC	blood vessel:	n/a
48	chr6:164767056-164767106	HRPEpiC	eye:	n/a
49	chr6:165032124-165032174	HCT-116	colon:	n/a
50	chr6:165032072-165032122	ovcar-3	ovarian:	n/a

(count:59 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr6:164862673..164864670-chr6:164866180..164868156,2	K562	blood:
2	chr6:164974094..164976654-chr6:164987580..164991765,3	K562	blood:
3	chr6:164943103..164945490-chr6:164951248..164953495,2	K562	blood:
4	chr6:164944443..164946258-chr6:164955428..164957824,2	K562	blood:
5	chr6:164862673..164864670-chr6:164866180..164868156,2	K562	blood:
6	chr6:164767711..164769131-chr6:165340232..165341669,7	MCF-7	breast:
7	chr6:164860412..164863160-chr6:164883552..164885284,2	K562	blood:
8	chr6:164876917..164879487-chr6:164880579..164883020,3	K562	blood:
9	chr6:164826913..164829845-chr6:164834931..164836483,2	MCF-7	breast:
10	chr6:164796151..164797865-chr6:164799819..164802680,2	K562	blood:
11	chr6:164877377..164879077-chr6:164881330..164883684,2	K562	blood:
12	chr6:164711353..164714302-chr6:164897118..164899591,2	K562	blood:
13	chr6:165007452..165009387-chr6:165042540..165044932,2	K562	blood:
14	chr6:164925048..164927475-chr6:164929518..164932281,2	K562	blood:
15	chr6:164796151..164797865-chr6:164799819..164802680,2	K562	blood:
16	chr6:164814459..164817291-chr6:164821398..164824476,3	K562	blood:
17	chr6:164826913..164829845-chr6:164834931..164836483,2	MCF-7	breast:
18	chr6:164925048..164927475-chr6:164929518..164932281,2	K562	blood:
19	chr6:164781175..164783778-chr6:164784737..164786491,2	K562	blood:
20	chr6:164798125..164802014-chr6:164802831..164806274,3	K562	blood:
21	chr6:164563456..164565737-chr6:164880821..164882711,2	K562	blood:
22	chr6:164860906..164865070-chr6:164865678..164869874,4	K562	blood:
23	chr6:164768200..164769032-chr6:165340931..165341635,2	MCF-7	breast:
24	chr6:165029398..165031412-chr6:165033183..165034759,2	K562	blood:
25	chr6:164797286..164799479-chr6:164818764..164821424,2	K562	blood:
26	chr6:164944443..164946258-chr6:164955428..164957824,2	K562	blood:
27	chr6:164767365..164769035-chr6:164822554..164824204,2	K562	blood:
28	chr6:164798125..164802014-chr6:164802831..164806274,3	K562	blood:
29	chr6:164754441..164757188-chr6:164816379..164818209,2	K562	blood:
30	chr6:164798340..164800182-chr6:164837678..164840406,2	K562	blood:
31	chr6:164921896..164924065-chr6:164926926..164929032,3	K562	blood:
32	chr6:164752284..164754596-chr6:164826369..164828641,2	K562	blood:
33	chr6:164797286..164799479-chr6:164818764..164821424,2	K562	blood:
34	chr6:164974094..164976654-chr6:164987580..164991765,3	K562	blood:
35	chr6:164686752..164688649-chr6:164926400..164929069,2	K562	blood:
36	chr6:164921896..164924065-chr6:164926926..164929032,3	K562	blood:
37	chr6:164877377..164879077-chr6:164881330..164883684,2	K562	blood:
38	chr6:164814585..164816801-chr6:164819045..164822898,3	K562	blood:
39	chr6:164768274..164768906-chr6:165033273..165034147,2	MCF-7	breast:
40	chr6:164943103..164945490-chr6:164951248..164953495,2	K562	blood:
41	chr6:164860412..164863160-chr6:164883552..164885284,2	K562	blood:
42	chr6:164815480..164817452-chr6:164823900..164826799,2	K562	blood:
43	chr6:164814585..164816801-chr6:164819045..164822898,3	K562	blood:
44	chr6:164768274..164768906-chr6:165033273..165034147,2	MCF-7	breast:
45	chr6:164757750..164761032-chr6:164766105..164769189,4	K562	blood:
46	chr6:164814459..164817291-chr6:164821398..164824476,3	K562	blood:
47	chr6:165007452..165009387-chr6:165042540..165044932,2	K562	blood:
48	chr6:164752242..164755007-chr6:164766257..164769251,2	K562	blood:
49	chr6:164663964..164666886-chr6:164937813..164940222,2	K562	blood:
50	chr6:164767365..164769035-chr6:164822554..164824204,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C6orf118-2	chr6:164767522-164767642	XLOC_005914
2	lnc-C6orf118-2	chr6:164769333-164769677	XLOC_005914

No data

Variant related genes	Relation type
ENSG00000226739	TF binding region
ENSG00000226739	CpG island
HIVEP2	miRNA target sites

Extended variants
information (count: 5658 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:5658 , 50 per page) page: 1 2 3 4 5 6 7 ... 114

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs370543247	chr6:164765943-164765944	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs573665269	chr6:164765950-164765951	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs73254414	chr6:164765973-164765974	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs550838913	chr6:164766019-164766020	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs77216805	chr6:164766053-164766054	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs544532379	chr6:164766087-164766088	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs554719866	chr6:164766112-164766113	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs375715800	chr6:164766123-164766124	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs9347838	chr6:164766124-164766125	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs397888374	chr6:164766133-164766134	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs540279366	chr6:164766134-164766135	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs560028724	chr6:164766136-164766137	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs539609869	chr6:164766139-164766140	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs370455231	chr6:164766169-164766170	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs545431175	chr6:164766170-164766171	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs577852570	chr6:164766176-164766177	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs377182141	chr6:164766181-164766182	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs558342079	chr6:164766188-164766189	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs183388673	chr6:164766199-164766200	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs182764871	chr6:164766200-164766201	Active TSS Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs550867457	chr6:164766238-164766239	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs534287724	chr6:164766239-164766240	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs374434721	chr6:164766268-164766269	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs187396508	chr6:164766294-164766295	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs564056832	chr6:164766298-164766299	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs76188242	chr6:164766302-164766303	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs192239640	chr6:164766305-164766306	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs566880760	chr6:164766315-164766316	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs183122119	chr6:164766325-164766326	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs561543232	chr6:164766329-164766330	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs558958089	chr6:164766342-164766343	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs569293006	chr6:164766375-164766376	Active TSS Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs77549983	chr6:164766403-164766404	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs574563342	chr6:164766466-164766467	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs188190282	chr6:164766493-164766494	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs547541115	chr6:164766519-164766520	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs553817197	chr6:164766523-164766524	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs576498100	chr6:164766534-164766535	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs545518840	chr6:164766550-164766551	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs562098328	chr6:164766553-164766554	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs76737473	chr6:164766574-164766575	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs793979	chr6:164766576-164766577	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs561473157	chr6:164766580-164766581	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs192785313	chr6:164766590-164766591	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs565590923	chr6:164766596-164766597	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs76074156	chr6:164766608-164766609	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs149833752	chr6:164766622-164766623	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs145742208	chr6:164766669-164766670	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs186658457	chr6:164766672-164766673	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs552705161	chr6:164766681-164766682	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	19435819	CNVD
Ovarian cancer	21720365	CNVD
Glioblastoma multiforme	21138945	CNVD
Ovarian cancer	22355333	CNVD
abnormal development	18461090	CNVD
Epilepsy	22083797	CNVD
Myelofibrosis	22110671	CNVD
chordoma	19801981	CNVD
Myxofibrosarcoma	16751306	CNVD
Autism	17483303	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Acute myeloid leukemia	19651601	CNVD
Sudden cardiac death	19188705	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:623 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:164758800-164767000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr6:164761800-164766200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
3	chr6:164763000-164767800	Weak transcription	Right Atrium	heart
4	chr6:164764200-164766200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
5	chr6:164764800-164766200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
6	chr6:164764800-164766400	Weak transcription	H1 Cell Line	embryonic stem cell
7	chr6:164765000-164766200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
8	chr6:164765600-164766000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr6:164765600-164766200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr6:164765600-164766400	Enhancers	Cortex derived primary cultured neurospheres	brain
11	chr6:164765800-164766000	Enhancers	H9 Cell Line	embryonic stem cell
12	chr6:164765800-164766000	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
13	chr6:164765800-164766200	Enhancers	HUES6 Cell Line	embryonic stem cell
14	chr6:164765800-164766200	Active TSS	iPS-20b Cell Line	embryonic stem cell
15	chr6:164765800-164766200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr6:164765800-164766400	Active TSS	ES-I3 Cell Line	embryonic stem cell
17	chr6:164765800-164767000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
18	chr6:164766000-164766200	Enhancers	HUES64 Cell Line	embryonic stem cell
19	chr6:164766000-164766200	Enhancers	iPS-18 Cell Line	embryonic stem cell
20	chr6:164766000-164766400	Weak transcription	H9 Cell Line	embryonic stem cell
21	chr6:164766000-164766600	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr6:164766000-164766800	Enhancers	Fetal Stomach	stomach
23	chr6:164766000-164767200	Enhancers	K562	blood
24	chr6:164766200-164766400	Active TSS	HUES48 Cell Line	embryonic stem cell
25	chr6:164766200-164766400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
26	chr6:164766200-164766600	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
27	chr6:164766200-164766600	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
28	chr6:164766200-164766800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
29	chr6:164766200-164766800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr6:164766200-164766800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
31	chr6:164766200-164767000	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr6:164766200-164767000	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr6:164766200-164767000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
34	chr6:164766200-164767800	Enhancers	iPS-15b Cell Line	embryonic stem cell
35	chr6:164766400-164766600	Enhancers	HUES6 Cell Line	embryonic stem cell
36	chr6:164766400-164766600	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
37	chr6:164766400-164767000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
38	chr6:164766400-164767600	Enhancers	Brain Anterior Caudate	brain
39	chr6:164766400-164767600	Enhancers	Brain Substantia Nigra	brain
40	chr6:164766400-164767800	Enhancers	Fetal Heart	heart
41	chr6:164766400-164768000	Enhancers	H1 Cell Line	embryonic stem cell
42	chr6:164766400-164768000	Enhancers	H9 Cell Line	embryonic stem cell
43	chr6:164766400-164768400	Enhancers	ES-I3 Cell Line	embryonic stem cell
44	chr6:164766600-164766800	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
45	chr6:164766600-164766800	Enhancers	Cortex derived primary cultured neurospheres	brain
46	chr6:164766600-164767400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
47	chr6:164766600-164767600	Enhancers	HUES64 Cell Line	embryonic stem cell
48	chr6:164766600-164768000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
49	chr6:164766600-164768000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
50	chr6:164766600-164768200	Enhancers	Fetal Adrenal Gland	Adrenal Gland

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links